Urology
Volume 75, Issue 2 , Page 392 , February 2010

Reply

References 

  1. Herr HW. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2008;54:126–132
  2. Rodel C, Grabenbauer GG, Kuhn R, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol. 2002;20:3061–3071
  3. Koga F, Yoshida S, Kawakami S, et al. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008;72:384–388
  4. Kihara K, Kawakami S, Fujii Y, et al. Gasless single port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIES. Int J Urol. 2009;16:791–800
  5. Koga F, Kihara K, Fujii Y, et al. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009;104:189–194

PII: S0090-4295(09)02512-6

doi: 10.1016/j.urology.2009.08.067

Urology
Volume 75, Issue 2 , Page 392 , February 2010

Article Tools